2CUREX — 2cureX AB Income Statement
0.000.00%
- SEK11.09m
- -SEK2.31m
- SEK0.16m
Annual income statement for 2cureX AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0.09 | 0.155 |
Cost of Revenue | |||||
Gross Profit | -9.38 | -10.1 | -11.9 | -12.3 | -12.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8.75 | 7.42 | 22.8 | 32.2 | 36.5 |
Operating Profit | -8.75 | -7.42 | -22.8 | -32.1 | -36.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -9.41 | -8.59 | -22.5 | -29.8 | -37.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.93 | -7.32 | -18.9 | -29.8 | -32.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.93 | -7.32 | -18.9 | -29.8 | -32.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.93 | -7.32 | -18.9 | -29.8 | -32.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.683 | -0.538 | -2.37 | -1.69 | -1.85 |
Dividends per Share |